| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |